<DOC>
	<DOCNO>NCT01864551</DOCNO>
	<brief_summary>The investigator hypothesize olanzapine superior lamotrigine prevention kind recurrence bipolar disorder . On hand , lamotrigine group well prevention depressive episode olanzapine group . Meanwhile , investigator suppose concomitant medicine lamictal group olanzapine group . The comorbidity influence measurement outcome time period recurrence depressive episode groups..</brief_summary>
	<brief_title>Olanzapine Compared Lamotrigine Prevention Depressive Episode Patients With Bipolar Disorder</brief_title>
	<detailed_description>Background : Bipolar disorder highly recurrent disease great impact function patient . Depressive symptom consist 50 % life time illness may lead self harm suicidal behavior . Lamotrigine , kind mood stabilizer , prove effective prevent depressive episode Bipolar disorder . However , still lack evidence monotherapy atypical antipsychotic olanzapine efficacy prevent recurrence depressive episode patient bipolar disorder although demonstrate good prevention manic episode bipolar disorder . Methods : The investigator enroll 60 patient bipolar disorder remission state least two month already receive olanzapine lamotrigine maintenance treatment . The patient maintain olanzapine applied olanzapine group ( N=30 ) whereas maintain lamotrigine applied lamotrigine group ( N=30 ) one month enter study . They follow 12 month . The demography data compare two group . The concomitant medicine maintenance period subject recruit recorded analyzed . The time period recurrence depressive episode compare group . In addition , investigate independent factor comorbid substance use disorder , alcohol use disorder , personality disorder , psychiatric disorder ( posttraumatic stress disorder , eat disorder ) , medical illness correlate high recurrent rate depressive episode bipolar disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>The patient age 15 50 bipolar disorder define DSMIV remission state ( YMRS &lt; 12 , HAMD &lt; 7 , CDR &lt; 3 ) least two month already receive olanzapine lamotrigine maintenance treatment one month . In addition , least three hypomanic , manic , depressive mixed episode previously . 1 . The patient willing participate study detailed explanation . 2 . The patient could follow investigator ' instruction 3 . The patient severe neurological mental illness like epileptic disorder , history stroke , schizophrenia , schizoaffective disorder , mental retardation uncontrolled suicide risk . 4 . The patient severe medical illness surgical condition like uncontrolled abnormal thyroid function , history heart attack , uncontrolled hypertension . 5 . The patient take mood stabilizer antipsychotic within one month prior evaluation enter study . 6 . The patient take medication might interfere metabolism olanzapine lamotrigine . 7 . The patient allergy olanzapine lamotrigine .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>